Filing Analysis
Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc. effective April 30, 2026. He has transitioned into a consulting role through a subsidiary, HITChain Inc., where he will receive monthly fees and a significant equity grant.
Red Flags
- Departure of a C-suite officer (Chief AI & Marketing Officer).
- Transition of a former officer to a consultant role, which can sometimes indicate a negotiated exit strategy.
- Issuance of 500,000 shares in a subsidiary (HITChain Inc.) rather than the parent company, which may complicate the corporate structure.
Key Facts
- Dustin Plantholt departed as Chief AI & Marketing Officer effective April 30, 2026.
- The departure is described as part of a 'business transition' and not a disagreement with the company.
- Plantholt entered into a Consulting Agreement via Plantholt Advisory Group LLC with subsidiary HITChain Inc. starting May 1, 2026.
- The consultant will receive monthly compensation and 500,000 restricted shares of HITChain Inc. common stock.
- The Restricted Stock Award vests in equal monthly installments over 12 months.
- The Consulting Agreement can be terminated by either party upon 10 days' prior written notice.
Health In Tech, Inc. furnished an investor presentation on March 25, 2026, intended for use at upcoming conferences and meetings. The filing serves as a standard Regulation FD disclosure to ensure public access to information shared with investors.
Key Facts
- The company prepared an investor presentation for use at conferences and meetings starting March 25, 2026.
- The presentation is furnished as Exhibit 99.1.
- The filing was made under Item 7.01 (Regulation FD Disclosure).
- Health In Tech, Inc. is classified as an emerging growth company.
- The company's Class A Common Stock is traded on the Nasdaq Capital Market under the symbol HIT.
Health In Tech, Inc. announced the closing of its previously disclosed private investment in public equity (PIPE) financing on March 27, 2026. The company issued a press release to confirm the completion of the capital raise, though specific dollar amounts and share counts were not detailed in the main body of the 8-K.
Red Flags
- PIPE financings in micro-cap companies are typically dilutive to existing Class A Common Stock holders.
- The 8-K lacks specific financial terms (valuation, share price, or total proceeds) within the narrative, relying on an exhibit.
Key Facts
- The company closed a PIPE financing on March 27, 2026.
- The transaction was previously announced and has now reached finality.
- Health In Tech, Inc. is listed on the Nasdaq Capital Market under the ticker HIT.
- The filing was signed by CEO Tim Johnson.
Health In Tech, Inc. entered into a securities purchase agreement for a $7.0 million PIPE financing involving the issuance of 5,600,000 shares of common stock to accredited investors. The company intends to use the proceeds for sales expansion, technology development, and working capital.
Red Flags
- Significant dilution of existing shareholders through the issuance of 5.6 million new shares.
- The use of a PIPE (Private Investment in Public Equity) often suggests a need for rapid capital that may not be available through traditional public offerings.
Key Facts
- The company is issuing 5,600,000 shares of Class A Common Stock.
- Gross proceeds are expected to be approximately $7.0 million before fees.
- The transaction is a Private Investment in Public Equity (PIPE) scheduled to close around March 27, 2026.
- Craig-Hallum Capital Group LLC served as the sole placement agent.
- The company must file a resale registration statement within 30 calendar days of the agreement.
- Directors and officers are subject to a 60-day lock-up period following the effectiveness of the registration statement.
Health In Tech, Inc. issued a press release on March 25, 2026, announcing its financial results for the fourth quarter and full fiscal year ended December 31, 2025.
Key Facts
- The filing reports financial results for the period ended December 31, 2025.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
- The company is an emerging growth company listed on the Nasdaq Capital Market under the ticker 'HIT'.
- Tim Johnson is identified as the Chief Executive Officer.